×
xylyx ☰
xylyx
by Tissue Type by Application

Cancer Metastasis

Xylyx Bio offers bone-, liver-, and lung-derived ECM biomaterials as 2D surface coating (NativeCoat™) and 3D hydrogel (TissueSpec®) kits for cancer metastasis applications.

Click here to make purchases outside of the U.S.A.


Available Lines

MTSMS101 MTSMS201 2D IN SITE™ Metastasis Surface Coating Kit (3x1mL) $ 159.00
MTSMS201 MTSMS101 3D IN SITE™ Metastasis Hydrogel Kit (3x1mL) $ 399.00

Relevant Applications

Cancer research
Drug discovery

Custom ECMs

Xylyx Bio specializes in isolating extracellular matrix from various tissue types and can prepare the biomaterials in formats that are compatible with advanced cell culture techniques.

Related Resources

Publication: Targeting Metabolic Adaptations in The Breast Cancer-Liver Metastatic Niche Using Dietary Approaches to Improve Endocrine Therapy Efficacy (2022)
Publication: Combined Targeting of Estrogen Receptor Alpha and Exportin 1 in Metastatic Breast Cancers (2020)
White Paper: 3D Lung Tumor Model with Lung Extracellular Matrix to Predict Drug Efficacy
Application Note: IN SITE™ Metastasis Kit to Accelerate Anticancer Drug Development
Supporting Protocol: Migration Assay with TissueSpec® ECM Hydrogel Kit
Supporting Protocol: Invasion Assay with TissueSpec® ECM Hydrogel Kit
Instructions for Use: IN SITE™ Metastasis Surface Coating Kit
Instructions for Use: IN SITE™ Metastasis Hydrogel Kit